Scientists developed a new exosome-based CRISPR/Cas9 gene-editing Platform | Current Affairs | Vision IAS
News Today Logo

    Scientists developed a new exosome-based CRISPR/Cas9 gene-editing Platform

    Posted 10 Jun 2024

    2 min read

    safeEXO-Casexosome-based platform has been developed by Scientists at Columbia University .

    • Exosomes are naturally occurring vesicles that have the potential to be manipulated to become promising drug delivery vehicles for on-demand in vitro and in vivo gene editing.

    It significantly enhances the delivery of CRISPR/Cas9 genome editing components to specific cells.

    • It will also facilitate development of the precision medicine and will improve cancer treatment. 
      • Precision medicine (aka personalized medicine) involves disease prevention and treatment that takes into account differences in people's genes, environments, and lifestyles.

    About CRISPR/Cas9 Technology

    • Clustered Regularly Interspaced Short Palindromic Repeats Associated protein 9 (CRISPR-Cas9) is a type of genome editing technology.
      • It is utilised to change genetic code or edit Deoxyribonucleic acid (DNA) at particular locations.
    • Working
      • Works as cut and paste mechanism on DNA Strands. Genetic codes that need to be changed are identified. 
      • Cas9 protein is used as a pair of molecular scissors to cut off a part from strand, allowing modifications to the genome.
    • Applications of CRISPR: Edit genes in human embryo; Change genetic codes of crops to improve crop resilience; treating diseases like sickle cell disease etc.
    • Tags :
    • CRISPR
    • Cas9
    • safeEXO-Cas
    Watch News Today
    Subscribe for Premium Features

    Quick Start

    Use our Quick Start guide to learn about everything this platform can do for you.
    Get Started